Company Quick10K Filing
Aemetis
Price1.04 EPS-1,547
Shares0 P/E-0
MCap0 P/FCF-0
Net Debt196 EBIT-16
TEV196 TEV/EBIT-12
TTM 2019-09-30, in MM, except price, ratios
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-12
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-15
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-29
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-03-17
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-12
10-K 2015-12-31 Filed 2016-03-29
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-11
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-07-31
10-Q 2013-03-31 Filed 2013-05-15
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-10-31
10-Q 2012-03-31 Filed 2012-10-31
10-K 2011-12-31 Filed 2012-10-31
10-Q 2010-09-30 Filed 2010-12-01
10-Q 2010-06-30 Filed 2010-09-28
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-03-15
8-K 2020-06-04
8-K 2020-05-14
8-K 2020-04-25
8-K 2020-03-12
8-K 2020-02-11
8-K 2020-01-31
8-K 2019-12-31
8-K 2019-11-14
8-K 2019-09-11
8-K 2019-08-08
8-K 2019-07-17
8-K 2019-05-21
8-K 2019-05-09
8-K 2019-04-24
8-K 2019-03-14
8-K 2018-12-24
8-K 2018-12-20
8-K 2018-12-03
8-K 2018-11-07
8-K 2018-08-23
8-K 2018-08-09
8-K 2018-05-17
8-K 2018-05-10
8-K 2018-03-29
8-K 2018-02-27

AMTX 8K Current Report

Aemetis Report 2020-02-11

8-K 1 amtx_8k.htm CURRENT REPORT Blueprint
 

  UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 11, 2020
 
AEMETIS, INC.
(Exact name of registrant as specified in its charter)
 
______________
 
Nevada
001-36475
26-1407544
(State or Other Jurisdiction
 of Incorporation)
(Commission
 File Number)
(I.R.S. Employer
 Identification No.)
 
20400 Stevens Creek Blvd., Suite 700
Cupertino, California 95014
(Address of Principal Executive Office) (Zip Code)
 
(408) 213-0940
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report)
 
Title of class of registered securities
Common Stock, par value $0.001 per share
Ticker Symbol
AMTX
Name of exchange on which registered
NASDAQ
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 

 
 
 
Item 3.01. Failure to Satisfy a Continued Listing Rule or Standards
 
On February 11, 2020, Aemetis, Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the most recent publicly held shares information and the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company did not meet the minimum market value of publicly held shares (“MVPHS”) of $15,000,000 required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(3)(C). A delisting notice has not been received, and the letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until August 10, 2020, in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(D). The letter further provided that if, at any time during the 180 calendar day period, the Company’s MVPHS closes at $15,000,000 or more for a minimum of ten consecutive business days, Nasdaq will provide the Company with written confirmation that it has achieved compliance with the MVPHS requirement. If the Company does not regain compliance by August 10, 2020, it will receive written notification that the Company’s common stock is subject to delisting. At that time, the Company may appeal the delisting determination to a Hearing’s Panel, which may provide an exception for the Company to regain compliance with the MVPHS requirement.
 
The Company intends to actively monitor the MVPHS for its common stock between now and August 10, 2020, and intends to take any reasonable actions to resolve the Company’s noncompliance with the MVPHS requirement as may be necessary. No determination regarding the Company’s response has been made at this time. There can be no assurance that the Company will be able to regain compliance with the MVPHS requirement or will otherwise be in compliance with other Nasdaq listing criteria.
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Aemetis, Inc.
 
 
 
 
 
February 13, 2020
By:
/s/ Eric A. McAfee
 
 
 
Eric A. McAfee
 
 
 
Chief Executive Officer